This inventor holds 1 USPTO granted patent. Top assignee: Pohang University of Science and Technology Foundation. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Min-Young Lee: A Pioneer in Nucleic Acid Delivery Innovations
Introduction: Min-Young Lee is an innovative inventor based in Pohang, South Korea, with a significant contribution to the field of nucleic acid delivery systems. Her groundbreaking work has earned her one patent, focusing on advancing the efficiency and stability of nucleic acid delivery using metal nanoparticles.
Latest Patents: The patent titled "Composition for nucleic acid delivery using metal nanoparticles and preparing method thereof" highlights her efforts in creating a composition that not only maintains excellent stability within the body but also enhances the efficiency of intracellular delivery of nucleic acids. This invention enables targeted delivery, offering promising applications in gene therapy and molecular medicine.
Career Highlights: Min-Young Lee is currently affiliated with the POSTECH Academy-Industry Foundation, where she applies her expertise to innovative research and development in the biotechnology sector. Her work aims to bridge the gap between academic research and industrial application, promoting advancements in medical technologies.
Collaborations: Throughout her career, she has collaborated with distinguished colleagues such as Sei Kwang Hahn and Kitae Park. These partnerships foster a dynamic research environment, facilitating the exploration of new ideas and technological advancements in nucleic acid delivery.
Conclusion: Min-Young Lee's contributions to nucleic acid delivery through her inventive work exemplify the spirit of innovation in the biotechnology field. Her ongoing research and partnerships at the POSTECH Academy-Industry Foundation are critical in shaping the future of targeted therapeutics and enhancing delivery methods in gene therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile